Orthotopic Hind-Limb Transplantation in Rats

Robert Sucher; Rupert Oberhuber; Christian Margreiter; Guido Rumberg; Rishi Jindal; WP Andrew Lee; Raimund Margreiter; Johann Pratschke; Stefan Schneeberger; Gerald Brandacher

doi:10.3791/2022

Orthotopic Hind-Limb Transplantation in Rats

JoVE Journal
Immunology and Infection
Author Produced

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Immunology and Infection

Orthotopic Hind-Limb Transplantation in Rats

Full Text

12,315 Views

14:03 min

July 12, 2010

DOI: 10.3791/2022-v

Robert Sucher*¹, Rupert Oberhuber*¹, Christian Margreiter¹, Guido Rumberg¹, Rishi Jindal², WP Andrew Lee², Raimund Margreiter¹, Johann Pratschke¹, Stefan Schneeberger¹, Gerald Brandacher¹

¹Department of Visceral, Transplant, and Thoracic Surgery, Daniel Swarovski Research Laboratory,Innsbruck Medical University, ²Department of Surgery, Division of Plastic and Reconstructive Surgery,University of Pittsburgh Medical Center

Overview

This article describes the orthotopic rat hind-limb transplantation procedure, which serves as a gold standard in vivo model for composite tissue allotransplantation research. The procedure is utilized to study ischemia and reperfusion injuries as well as immunological events related to allograft rejection.

Key Study Components

Area of Science

Composite tissue allotransplantation
Ischemia and reperfusion injury
Immunological responses

Background

The study focuses on limb transplantation in a rat model.
It aims to understand the mechanisms of tissue rejection.
Research includes strategies to minimize immunosuppression.
The cuff technique for revascularization is introduced.

Purpose of Study

To demonstrate the limb transplantation procedure.
To explore immunological events during allograft rejection.
To investigate methods to prevent rejection.

Methods Used

Orthotopic hind-limb transplantation in rats.
Use of surgical residents for the procedure.
Implementation of a cuff technique for revascularization.
Monitoring of ischemia and reperfusion injuries.

Main Results

Successful demonstration of the transplantation procedure.
Insights into immunological responses during rejection.
Evaluation of targeted immunomodulatory regimens.
Potential strategies to reduce maintenance immunosuppression.

Conclusions

The orthotopic rat model is effective for studying allotransplantation.
Understanding ischemia and reperfusion is critical for improving outcomes.
Targeted immunomodulation may enhance graft survival.

Frequently Asked Questions

What is the significance of the rat hind-limb transplantation model?

It serves as a gold standard for studying composite tissue allotransplantation.

What are the main focuses of this study?

The study focuses on ischemia, reperfusion injuries, and immunological responses.

What technique is introduced for revascularization?

A cuff technique is introduced for effective revascularization during transplantation.

How does this research contribute to immunosuppression strategies?

It explores targeted immunomodulatory regimens to minimize the need for maintenance immunosuppression.

Who performs the limb transplantation surgery?

The surgery is performed by surgical residents under supervision.

What are the expected outcomes of this transplantation model?

The model aims to improve understanding of graft rejection and enhance survival strategies.

Here we describe the orthotopic rat hind-limb transplantation procedure, which seems to be the gold standard in vivo model for composite tissue allotransplantation research.

I am Robert Suha from the Daniels Roski Research Laboratory of the Department of Visceral Transplant and Thoracic Surgery from Innsbrook Medical University. Today we are going to show you the procedure of he limb transplantation in the red, introducing a cuff technique for revascularization. This he limb transplantation surgery is performed by our surgical residents, including myself.

We use this animal model to study ischemia and reperfusion associated injuries in a composite tissue allograft. Furthermore, we use this procedure to study immunological events of composite tissue allograft rejection, as well as strategies to prevent rejection from occurring. These strategies include the minimization or even avoidance of maintenance immunosuppression through the use of targeted immunomodulatory regimens.

View the full transcript and gain access to thousands of scientific videos